Secondary resection in a general mCRC population with cetuximab-based first-line treatment: Interim analysis of the german noninterventional study ERBITAG Posted on 1. Januar 201318. Mai 2017 by friebelwv Autoren: Ulf P Neumann, Thomas Goehler, Gernot Reich, Michael Schwerdtfeger, Patrick Stuebs, Karsten G Stenzel, Friedrich Overkamp ASCO 2013